Dr. Diekman has established a research laboratory that utilizes regenerative medicine technologies to develop novel therapeutic approaches for osteoarthritis. One goal of the lab is to use engineered cartilage tissue as a model system to understand the mechanisms by which aging contributes to cartilage dysfunction and to screen for drugs that prevent cartilage dysfunction. The lab also uses genome editing of stem cells to investigate the genetic risk factors for osteoarthritis. In addition to experiments with cultured cells, work with rodent models allows the lab to test the feasibility of interventions designed to increase the regenerative capacity of cartilage tissue after injury.
F32 (NIH NRSA Individual Postdoctoral Fellowship / National Institute on Aging) 2015-2017
Wake Forest Institute for Regenerative Medicine Young Investigator Award 2011